CAMP

Camp 4 Therapeutics Stock Analysis

AI Rating

Good
  • Quality2/10
  • Growth↑ 9/10
  • Momentum↑ 8/10
Camp 4 Therapeutics sales and earnings growth
CAMP Growth
Great
  • Revenue Y/Y↓ 0.00%
  • EPS Y/Y↑ 159.54%
  • FCF Y/Y↓ -2.50%
Camp 4 Therapeutics gross and profit margin trends
CAMP Profitability
Neutral
  • Gross margin ↑ 100.00%
  • EPS margin↓ -1404.50%
  • ROIC↓ -490.20%
Camp 4 Therapeutics net debt vs free cash flow
CAMP Risk
Great
  • Debt / Equity↓ 0.1
  • Debt / FCF↓ 0.0
  • Interest coverage↓ NA

Camp 4 Therapeutics stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

More Biotechnology stocks ↗